drugset / Trial / NCT00750529

Alzheimer and Sleep

NCT00750529

RandomizedCrossoverOpen-labelTreatment

Summary

The aim of the study is the analysis of two inhibitors of Ach-E: galantamine and donépézil in over 65 years' old patients suffering from Alzheimer disease (MMSE between 20 and 26) without Alzheimer's medication.

Timeline

Start
2008-11
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule
Subject Galantamine Small molecule

Indications